These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24767688)
81. Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery. Steineck G; Bjartell A; Hugosson J; Axén E; Carlsson S; Stranne J; Wallerstedt A; Persson J; Wilderäng U; Thorsteinsdottir T; Gustafsson O; Lagerkvist M; Jiborn T; Haglind E; Wiklund P; Eur Urol; 2015 Mar; 67(3):559-68. PubMed ID: 25457018 [TBL] [Abstract][Full Text] [Related]
82. Comparative analysis of short - term functional outcomes and quality of life in a prospective series of brachytherapy and Da Vinci robotic prostatectomy. García-Sánchez C; Martín AA; Conde-Sánchez JM; Congregado-Ruíz CB; Osman-García I; Medina-López RA Int Braz J Urol; 2017; 43(2):216-223. PubMed ID: 28128908 [TBL] [Abstract][Full Text] [Related]
83. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer. Mazur DJ; Merz JF J Am Geriatr Soc; 1995 Sep; 43(9):979-84. PubMed ID: 7657938 [TBL] [Abstract][Full Text] [Related]
84. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. Smith DP; King MT; Egger S; Berry MP; Stricker PD; Cozzi P; Ward J; O'Connell DL; Armstrong BK BMJ; 2009 Nov; 339():b4817. PubMed ID: 19945997 [TBL] [Abstract][Full Text] [Related]
85. Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice. Singhal U; Hollenbeck BK; Kaffenberger SD; Salami SS; George AK; Skolarus TA; Montgomery JS; Wittmann DA; Miller DC; Wei JT; Palapattu GS; Montie JE; Dunn RL; Morgan TM J Urol; 2023 Nov; 210(5):771-777. PubMed ID: 37566643 [TBL] [Abstract][Full Text] [Related]
86. Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities. Muise A; Pan MM; Rose B; Buckley JC Urol Oncol; 2023 Feb; 41(2):104.e1-104.e9. PubMed ID: 36535862 [TBL] [Abstract][Full Text] [Related]
87. Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up. Carlsson S; Bock D; Lantz A; Angenete E; Koss Modig K; Hugosson J; Bjartell A; Steineck G; Wiklund P; Haglind E Scand J Urol; 2023 May; 58():11-19. PubMed ID: 37170656 [TBL] [Abstract][Full Text] [Related]
88. Functional results in the treatment of localized prostate cancer. An updated literature review. Garcia-Baquero R; Fernandez-Avila CM; Alvarez-Ossorio JL Rev Int Androl; 2019; 17(4):143-154. PubMed ID: 30473332 [TBL] [Abstract][Full Text] [Related]
89. Self-reported functional assessment after treatment for prostate cancer: 5-year results of the prospective cohort VICAN. Pignot G; Touzani R; Bendiane MK; Mancini J; Walz J; Marino P; Rybikowski S; Maubon T; Salem N; Gravis G; Bouhnik AD Future Oncol; 2022 May; 18(14):1733-1744. PubMed ID: 35172586 [TBL] [Abstract][Full Text] [Related]
90. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. O'Callaghan ME; Raymond E; Campbell J; Vincent AD; Beckmann K; Roder D; Evans S; McNeil J; Millar J; Zalcberg J; Borg M; Moretti K Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):378-388. PubMed ID: 28585573 [TBL] [Abstract][Full Text] [Related]
91. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. Lim AJ; Brandon AH; Fiedler J; Brickman AL; Boyer CI; Raub WA; Soloway MS J Urol; 1995 Oct; 154(4):1420-5. PubMed ID: 7658548 [TBL] [Abstract][Full Text] [Related]
92. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy. Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552 [TBL] [Abstract][Full Text] [Related]
93. [Study on the efficacy and complications of patients undergoing radical surgery and radical radiotherapy for localized prostate cancer]. Shi XQ; Wang SH; Liu Z; Lu LW; Xu S; Fu D; Cheng W Zhonghua Nan Ke Xue; 2023 Oct; 29(10):910-915. PubMed ID: 38639661 [TBL] [Abstract][Full Text] [Related]
94. Quality of life in men undergoing active surveillance for localized prostate cancer. Bergman J; Litwin MS J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780 [TBL] [Abstract][Full Text] [Related]
95. Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer. Sibert NT; Pfaff H; Breidenbach C; Wesselmann S; Roth R; Feick G; Carl G; Dieng S; Gaber AA; Blana A; Darr C; Distler F; Kunath F; Bedke J; Erdmann J; Minner J; Simon J; Kwiatkowski M; Burchardt M; Harz N; Conrad S; Höfner T; Knoll T; Beyer B; Hammerer P; Kowalski C World J Urol; 2022 Jun; 40(6):1437-1446. PubMed ID: 35347412 [TBL] [Abstract][Full Text] [Related]
96. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Jønler M; Ritter MA; Brinkmann R; Messing EM; Rhodes PR; Bruskewitz RC Urology; 1994 Dec; 44(6):876-82. PubMed ID: 7985316 [TBL] [Abstract][Full Text] [Related]
97. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Nguyen LN; Pollack A; Zagars GK Urology; 1998 Jun; 51(6):991-7. PubMed ID: 9609638 [TBL] [Abstract][Full Text] [Related]
98. External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects. Borg MA; O'Callaghan ME; Moretti KL; Vincent AD BMC Urol; 2024 Jan; 24(1):2. PubMed ID: 38166977 [TBL] [Abstract][Full Text] [Related]
99. The value of the marginalia as an adjunct to structured questionnaires: experiences of men after prostate cancer surgery. Powel LL; Clark JA Qual Life Res; 2005 Apr; 14(3):827-35. PubMed ID: 16022075 [TBL] [Abstract][Full Text] [Related]
100. Urinary and bowel symptoms in men with and without prostate cancer: results from an observational study in the Stockholm area. Adolfsson J; Helgason AR; Dickman P; Steineck G Eur Urol; 1998; 33(1):11-6. PubMed ID: 9471035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]